FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
Provided By GlobeNewswire
Last update: Jun 9, 2025
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025.
Read more at globenewswire.comNASDAQ:FGEN (10/30/2025, 8:07:56 PM)
11.04
+0.13 (+1.19%)
Find more stocks in the Stock Screener
